Wealthcare Advisory Partners
IGC icon

Wealthcare Advisory Partners’s IGC Pharma IGC Stock Holding History

Wealthcare Advisory Partners’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.69K Hold
10,000
– – ﹤0.01% 1111
2026
Q2 		$2.72K Hold
10,000
– – ﹤0.01% 1083
2026
Q1 		$2.63K Buy
+10,000
New +$2.78K ﹤0.01% 1073

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
AdvisorShares Investments
AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $145M AUM 29.71% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Schneider Downs Wealth Management Advisors
Schneider Downs Wealth Management Advisors Pittsburgh, Pennsylvania $1.08B AUM 10.9% 1-Year Est. Return
Geneos Wealth Management
Geneos Wealth Management Englewood, Colorado $5.32B AUM 16.49% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

Wealthcare Advisory Partners's IGC Position: Q3 2026 in Review

Wealthcare Advisory Partners held its IGC Pharma (IGC) position steady in Q3 2026 at 10,000 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #1111.

Wealthcare Advisory Partners first reported a position in IGC in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.72K in Q2 2026. 16 funds tracked by Wall St. Rank hold IGC as of Q3 2026.

  • Wealthcare Advisory Partners held 10,000 shares of IGC Pharma worth $2.69K as of Q3 2026.
  • Wealthcare Advisory Partners left its IGC Pharma share count unchanged in Q3 2026.
  • IGC Pharma made up ﹤0.01% of Wealthcare Advisory Partners's portfolio in Q3 2026, its #1111 holding.
  • Wealthcare Advisory Partners first reported a position in IGC Pharma in Q1 2026 and has held it in 3 quarters since.
  • Wealthcare Advisory Partners's IGC Pharma position peaked at $2.72K in Q2 2026.
  • 16 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q3 2026, filed 21 Oct 2026.